Homepage - Bayer HealthCare Pharmaceuticals

Medical progress for the benefit of the patient - Information from Bayer HealthCare Pharmaceuticals

Medical progress for the benefit of the patient - Information from Bayer HealthCare Pharmaceuticals

News

01/10/12, Bayer HealthCare Pharmaceuticals Phase III Data of Bayer’s Regorafenib in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Oral Presentation at 2012 ASCO-GI Congress Late breaking abstract (LBA #385) of Phase III CORRECT study results to be presented on January 21, 2012 more

1
2

9th International Dialogue

Image: 9th International Dialogue on Population and Sustainable Development

“Education Matters: Empowering Young People to Make Healthier Choices” more

Uganda: Better access to contraception

Partnership between Bayer and USAID provides better access to oral contraceptives more

The Labtour: From molecules to medicine

Which path does a molecule have to take to become a reliable pharmaceutical product? more

Publications

Stockholders' Newsletter Third Quarter 2011

Links

Oral contra- ceptives
Information on oral contraceptives
Clinical trials
More information
Grants 4 Targets

Grants 4 Targets

We allocate grants for the further develop- ment of promising novel molecular targets. more »

Share this:

A | A | A |

Last updated: 2012

Copyright © Bayer Pharma AG

http://www.bayerpharma.com/en/index.php

Copyright © Bayer Pharma AG